World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
125
Citations
65550
World Ranking
104
National Ranking
52

Medicine

D-Index
130
Citations
66786
World Ranking
2485
National Ranking
1401

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Amalio Telenti is a researcher affiliated with VIR Biotechnology in the United States. Their work primarily focuses on medicine and the intersection of biochemistry, genetics, and molecular biology. Within these broad disciplines, their research frequently addresses infectious diseases, molecular biology, animal science and zoology, epidemiology, and immunology.

Their main topics of study include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, animal virus infections, viral gastroenteritis research and epidemiology, vaccines and immunoinformatics approaches, long-term effects of COVID-19, and viral infections and immunology research.

Amalio Telenti has contributed extensively to various scientific venues. Key publication platforms for their work include bioRxiv (Cold Spring Harbor Laboratory), Nature, Cell, iScience, and Science.

Some of their recent scholarly papers are:

  • Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, 2020, Nature
  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift, 2021, Nature
  • N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2, 2021, Cell
  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity, 2021, Cell
  • SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape, 2021, Nature

Their recurring collaborators include:

  • Davide Corti
  • Herbert W. Virgin
  • Julia di Iulio
  • Elisabetta Cameroni
  • Gyorgy Snell

Their research spans multiple aspects of viral infection biology, with emphasis on understanding the immune response to SARS-CoV-2, mapping viral antigenic sites, and characterizing antibody resistance and neutralization. The focus on integrating clinical and molecular data aims to contribute to pandemic response and therapeutic strategies.

Best Publications

  • Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

    Dora Pinto;Young Jun Park;Martina Beltramello;Alexandra C. Walls

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

    A Telenti;P Imboden;F Marchesi;L Matter

  • Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

    A Telenti;F Marchesi;M Balz;F Bally

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

    Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob

  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

    Unknown

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

    Catia Marzolini;Amalio Telenti;Laurent A. Decosterd;Gilbert Greub

  • N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.

    Matthew McCallum;Anna De Marco;Florian A. Lempp;M. Alejandra Tortorici;M. Alejandra Tortorici

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • A primer on deep learning in genomics.

    James Zou;Mikael Huss;Abubakar Abid;Pejman Mohammadi

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses

    Silke Paust;Silke Paust;Harvinder S Gill;Harvinder S Gill;Bao-Zhong Wang;Michael P Flynn

  • Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

    Daniel Périard;Amalio Telenti;Philippe Sudre;Jean Jacques Cheseaux

  • Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.

    H. E. Takiff;L. Salazar;C. Guerrero;W. Philipp

  • The fecal metabolome as a functional readout of the gut microbiome.

    Jonas Zierer;Jonas Zierer;Matthew A. Jackson;Gabi Kastenmüller;Massimo Mangino;Massimo Mangino

  • THE EMB OPERON, A GENE CLUSTER OF MYCOBACTERIUM TUBERCULOSIS INVOLVED IN RESISTANCE TO ETHAMBUTOL

    Amalio Telenti;Wolfgang J. Philipp;Srinand Sreevatsan;Claudia Bernasconi

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis

    Amy S. Piatek;Sanjay Tyagi;Arno C. Pol;Amalio Telenti

Frequent Co-Authors

Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne
Hansjakob Furrer
Hansjakob Furrer University of Bern
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Laurent A. Decosterd
Laurent A. Decosterd University Hospital of Lausanne
Manuel Battegay
Manuel Battegay University Hospital of Basel
Thierry Buclin
Thierry Buclin University of Lausanne
Javier Martinez-Picado
Javier Martinez-Picado University of Vic - Central University of Catalonia
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Bruno Ledergerber
Bruno Ledergerber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career options within healthcare, research, and public health sectors. Many students also consider complementary fields that support microbiological work, such as health information management. Pursuing an accredited online health information management degree cahiim ensures industry-recognized credentials for managing patient data effectively.

For those interested in administrative roles in healthcare settings, especially related to medical documentation, earning certifications like the quickest medical billing and coding certificate online can boost employability and offer a fast entry into the field.

Additionally, students seeking advanced degrees often explore options beyond traditional on-campus programs. Exploring what medical degree can i get online provides valuable insight into flexible learning paths in medicine that can complement microbiology expertise.

Public health is another closely related area where microbiology professionals can thrive. Choosing from online public health masters programs easy to get into allows aspiring public health specialists to enhance their qualifications conveniently while addressing critical health challenges.

Best Scientists Citing Amalio Telenti

Trending Scientists